Literature DB >> 3036165

Down-regulation of surface beta-adrenoceptors on intact human mononuclear leukocytes. Time-course and isoproterenol concentration dependence.

D Sandnes, I Gjerde, M Refsnes, S Jacobsen.   

Abstract

Incubation of human mononuclear leukocytes (MNL) in vitro with isoproterenol resulted in a rapid loss of surface beta-adrenoceptors, determined by radioligand binding at 4 degrees. Isoproterenol concentrations in the range of 10 nM to 100 microM resulted in significant down-regulation of beta-adrenoceptors. At a concentration of 1 microM isoproterenol, the time-dependent loss of surface beta-adrenoceptors closely paralleled the loss in isoproterenol-stimulated adenylate cyclase activity. If receptor number in intact cells was determined at 32 degrees, hardly any loss in receptor number was observed, due to reversal of down-regulation during the incubation period. When beta-adrenoceptor number in broken cell preparations was determined by [125I]cyanopindolol binding at 37 degrees no significant loss was observed, even after 2 hr of isoproterenol treatment, while [3H]CGP-12177 binding resulted in a similar reduction in binding sites as in intact cells. Reversal of loss in surface beta-adrenoceptors was rapid after 1 hr pretreatment with isoproterenol, but followed a biphasic time course after 4 hr pretreatment, with an initial rapid return of about 40% of the down-regulated receptors, followed by a slow, gradual reappearance of receptors. The results indicate that catecholamine exposure leads to a rapid sequestration of MNL surface beta-adrenoceptors away from the cell surface, to a compartment where they are inaccessible to the hydrophilic ligand [3H]CGP-12177 as well as to the lipophilic ligand [125I]cyanopindolol at 4 degrees. Up to 2 hr of isoproterenol treatment does not lead to any breakdown of sequestered beta-adrenoceptors, as they are still recognized by [125I]cyanopindolol binding in broken cell preparations.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3036165     DOI: 10.1016/0006-2952(87)90086-4

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  5 in total

1.  Does treatment with beta-adrenergic blocking agents cause a decrease in beta 2-adrenoceptor affinity?

Authors:  W M Blankesteijn; S J Graafsma; M P Hectors; E A Olde Riekerink; J F Rodrigues de Miranda; T Thien
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

2.  Proceedings of the British Pharmacological Society. Nottingham, 7th-9th September 1988. Abstracts.

Authors: 
Journal:  Br J Pharmacol       Date:  1988-12       Impact factor: 8.739

3.  Adrenaline stimulated cyclic adenosine monophosphate response in leucocytes is reduced after prolonged physical activity combined with sleep and energy deprivation.

Authors:  P K Opstad; P Wiik; A H Haugen; K K Skrede
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1994

4.  Beta 2-adrenergic receptor regulation of human neutrophil function is sexually dimorphic.

Authors:  Catherine de Coupade; Robert W Gear; Paul F Dazin; Herve Y Sroussi; Paul G Green; Jon D Levine
Journal:  Br J Pharmacol       Date:  2004-10-11       Impact factor: 8.739

5.  Three basic residues of intracellular loop 3 of the beta-1 adrenergic receptor are required for golgin-160-dependent trafficking.

Authors:  Catherine E Gilbert; David M Zuckerman; Pamela L Currier; Carolyn E Machamer
Journal:  Int J Mol Sci       Date:  2014-02-20       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.